NCT04901429 Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass
| NCT ID | NCT04901429 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | GERD |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-07-01 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2021-07-01 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the efficacy of performing a truncal vagotomy along with a sleeve to bypass revision surgery in reducing the severity and/or incidence of gastroesophageal reflux disease (GERD) post-surgery.
Eligibility Criteria
Inclusion Criteria: * Participating subjects will need to be \>18yrs of age and eligible for sleeve to bypass revision bariatric surgery. * Undergoing sleeve to bypass revision bariatric surgery. Exclusion Criteria: * Patients who are under the age of 18. * Not eligible for sleeve to bypass revision bariatric surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04901429 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying GERD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04901429 currently recruiting?
Yes, NCT04901429 is actively recruiting participants. Contact the research team at ADVANCEDSURGERYRESEARCH@bswhealth.org for enrollment information.
Where is the NCT04901429 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT04901429 clinical trial?
NCT04901429 is sponsored by Baylor Research Institute. The trial plans to enroll 200 participants.